Non-mydriatic multicolour imaging


The latest advancement in optical imaging.

The latest advance in optical imaging is the addition of multicolour imaging to OCT cameras. I have experienced this technological advancement with Heidelberg Engineering's MultiColor technology for SPECTRALIS, which allows simultaneous scanning with three selective coloured lasers: infrared, green and blue. In this article, I will outline the basis of multicolour imaging, highlighting advantages and revealing my experiences.

Background to the MultiColor

Benefits across a range of diseases

One of the great benefits of OCT imaging is that it is non-invasive and non-mydriatic. The new SPECTRALIS models allow the user to capture an OCT image and at the same time a colour image that is very similar to a fundus image, without having to dilate the patient. Because the lasers are continually scanning, a live fundus image is delivered that makes camera alignment very easy. Moreover, the confocal optic suppresses scattered light and produces high contrast images, even in many patients with cataract. In my opinion, MultiColor images are excellent educational tools for the patient as they are much easier to understand than infrared images.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.